Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 1722 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1722 DOIs

Add abstracts to 884 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact884 DOIs

Add license metadata to 256 records

License metadata tells indexers and readers how each article may be reused.

Low impact256 DOIs

DOIs for this ISSN

Showing the top 5 of 2327 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Autosomal-dominant Alzheimer's disease: a review and proposa… (10.1186/alzrt59)	Abstract References ORCID License	263.35	429
2	The role of APP and BACE1 trafficking in APP processing and… (10.1186/alzrt211)	Abstract References ORCID License	228.78	193
3	Inflammation in Alzheimer's disease: relevance to pathogenes… (10.1186/alzrt24)	Abstract References ORCID License	228.10	190
4	Addressing the challenges to successful recruitment and rete… (10.1186/alzrt58)	Abstract References ORCID License	225.29	178
5	Promising developments in neuropsychological approaches for… (10.1186/alzrt222)	Abstract References ORCID License	222.01	165
6	Definitions of dementia and predementia states in Alzheimer'… (10.1186/alzrt198)	Abstract References ORCID License	217.32	148
7	Targeting norepinephrine in mild cognitive impairment and Al… (10.1186/alzrt175)	Abstract References ORCID License	213.67	136
8	The culprit behind amyloid beta peptide related neurotoxicit… (10.1186/alzrt36)	Abstract References ORCID License	210.72	127
9	Cerebral amyloid angiopathy in the aetiology and immunothera… (10.1186/alzrt6)	Abstract References ORCID License	209.34	123
10	Alzheimer’s disease prevention: from risk factors to early i… (10.1186/s13195-017-0297-z)	Abstract ORCID License	207.76	588
11	A phase III randomized trial of gantenerumab in prodromal Al… (10.1186/s13195-017-0318-y)	Abstract ORCID License	201.56	486
12	Pharmacological recommendations for the symptomatic treatmen… (10.1186/alzrt201)	Abstract References ORCID License	198.68	96
13	Whether, when and how chronic inflammation increases the ris… (10.1186/alzrt118)	Abstract References ORCID License	198.23	95
14	Adjusting the compass: new insights into the role of angioge… (10.1186/alzrt230)	Abstract References ORCID License	193.45	85
15	Beyond mild cognitive impairment: vascular cognitive impairm… (10.1186/alzrt4)	Abstract References ORCID License	191.91	82
16	Plasma tau levels in Alzheimer's disease (10.1186/alzrt163)	Abstract ORCID License	191.08	352
17	Proteinopathy-induced neuronal senescence: a hypothesis for… (10.1186/alzrt5)	Abstract References ORCID License	190.85	80
18	Clinical, imaging, and pathological heterogeneity of the Alz… (10.1186/alzrt155)	Abstract ORCID License	189.18	332
19	Genetics of Alzheimer disease in the pre- and post-GWAS era (10.1186/alzrt26)	Abstract References ORCID License	186.33	72
20	Amyloid β-protein oligomers and Alzheimer’s disease (10.1186/alzrt226)	Abstract ORCID License	181.12	259
21	Alcohol-related dementia: an update of the evidence (10.1186/alzrt157)	Abstract ORCID License	177.55	232
22	Evidence for impaired amyloid β clearance in Alzheimer's dis… (10.1186/alzrt187)	Abstract ORCID License	175.83	220
23	Importance of national plans for Alzheimer’s disease and dem… (10.1186/alzrt205)	Abstract References ORCID License	174.82	55
24	Clinical prevalence of Lewy body dementia (10.1186/s13195-018-0350-6)	Abstract ORCID License	174.48	211
25	Role of neuroinflammation in neurodegeneration: new insights (10.1186/s13195-017-0241-2)	Abstract ORCID License	174.32	210
26	Design and first baseline data of the DZNE multicenter obser… (10.1186/s13195-017-0314-2)	Abstract ORCID License	173.54	205
27	Monoamine oxidase B is elevated in Alzheimer disease neurons… (10.1186/s13195-017-0279-1)	Abstract ORCID License	173.22	203
28	Chronic traumatic encephalopathy: a spectrum of neuropatholo… (10.1186/alzrt234)	Abstract ORCID License	173.06	202
29	Dimebon disappointment (10.1186/alzrt49)	Abstract References ORCID License	170.76	50
30	Cognitive training and cognitive rehabilitation for persons… (10.1186/alzrt189)	Abstract ORCID License	170.21	185
31	Fyn kinase inhibition as a novel therapy for Alzheimer’s dis… (10.1186/alzrt238)	Abstract ORCID License	170.21	185
32	Autophagic/lysosomal dysfunction in Alzheimer’s disease (10.1186/alzrt217)	Abstract ORCID License	169.68	182
33	Mild traumatic brain injury: a risk factor for neurodegenera… (10.1186/alzrt42)	Abstract ORCID License	169.51	181
34	Molecular consequences of amyloid precursor protein and pres… (10.1186/alzrt107)	Abstract ORCID License	167.28	169
35	Tau passive immunization inhibits not only tau but also Aβ p… (10.1186/s13195-016-0227-5)	Abstract ORCID License	165.51	160
36	Dementia prevention: current epidemiological evidence and fu… (10.1186/alzrt104)	Abstract ORCID License	165.31	159
37	A new enzyme-linked immunosorbent assay for neurofilament li… (10.1186/s13195-018-0339-1)	Abstract ORCID License	165.10	158
38	Mitochondrial dysfunction - the beginning of the end in Alzh… (10.1186/alzrt74)	Abstract ORCID License	164.69	156
39	Lipidomics of Alzheimer's disease: current status (10.1186/alzrt103)	Abstract ORCID License	162.55	146
40	The involvement of cell cycle events in the pathogenesis of… (10.1186/alzrt37)	Abstract References ORCID License	161.28	40
41	Ayurvedic medicinal plants for Alzheimer's disease: a review (10.1186/alzrt125)	Abstract ORCID License	160.96	139
42	Perspectives on future Alzheimer therapies: amyloid-β protof… (10.1186/alzrt246)	Abstract ORCID License	160.25	136
43	Alzheimer's disease therapeutic research: the path forward (10.1186/alzrt2)	Abstract References ORCID License	159.11	38
44	Examining the mechanisms that link β-amyloid and α-synuclein… (10.1186/alzrt109)	Abstract ORCID License	157.27	124
45	Dominantly Inherited Alzheimer Network: facilitating researc… (10.1186/alzrt213)	Abstract ORCID License	157.27	124
46	Diffusion kurtosis imaging allows the early detection and lo… (10.1186/s13195-017-0329-8)	Abstract ORCID License	156.48	121
47	Accelerating drug discovery for Alzheimer's disease: best pr… (10.1186/alzrt90)	Abstract ORCID License	155.94	119
48	Plasma amyloid beta measurements - a desired but elusive Alz… (10.1186/alzrt162)	Abstract ORCID License	155.39	117
49	The β-secretase enzyme BACE1 as a therapeutic target for Alz… (10.1186/alzrt82)	Abstract ORCID License	154.27	113
50	Synaptic proteins in CSF as potential novel biomarkers for p… (10.1186/s13195-017-0335-x)	Abstract ORCID License	154.27	113